产品名称
6-重氮-5-氧代-L-正亮氨酸, powder
assay
≥95% (HPLC)
Quality Level
form
powder
technique(s)
ligand binding assay: suitable
color
faint yellow, to yellow or tan
antibiotic activity spectrum
neoplastics
mode of action
enzyme | inhibits
storage temp.
−20°C
SMILES string
N[C@@H](CCC(=O)C=[N+]=[N-])C(O)=O
InChI
1S/C6H9N3O3/c7-5(6(11)12)2-1-4(10)3-9-8/h3,5H,1-2,7H2,(H,11,12)/t5-/m0/s1
InChI key
YCWQAMGASJSUIP-YFKPBYRVSA-N
General description
化学结构:氨基酸衍生物
Application
6-重氮-5-氧代-L-正亮氨酸(DON)已用作谷氨酰胺合成酶 - 谷氨酰胺(酰胺)-2-氧代戊二酸氨基转移酶的抑制剂。
Biochem/physiol Actions
DON 与许多需要 L-谷氨酰胺作为氮源的反应有关,例如核酸和蛋白质合成。它已知具有抗绒毛膜癌的抗癌活性。
6-重氮-5-氧代-L-正亮氨酸(DON),谷氨酰胺类似物,用作抑制剂,研究胞苷三磷酸合成酶1(s)(CTPS1)和各种谷氨酰胺酶的功能、特异性和特征。DON 用于抑制细胞之间的谷氨酰胺(GLN)通量。
DON 用于研究谷氨酰胺利用酶的机制,例如氨基甲酰磷酸合成酶和胞苷三磷酸合成酶。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
法规信息
新产品
此项目有
商品
Sigma article discusses tumor cell metabolic pathways, focusing on aerobic glycolysis and mitochondrial activity.
本文介绍了增殖活性细胞为何需要碳源和氮源合成大分子。尽管大部分肿瘤细胞利用有氧糖酵解途径并分流线粒体氧化磷酸化代谢物,但许多肿瘤细胞表现出线粒体活性增加。
Yingyue Zhang et al.
Journal of agricultural and food chemistry, 67(30), 8411-8418 (2019-06-28)
Economic loss of postharvest wheat under poor storage conditions due to fungal spoilage and mycotoxin contamination is severe. In order to study the influencing factors of the aggravation of mildew in natural wheat during storage, we assessed changes in Fusarium
Laura M Shelton et al.
International journal of cancer, 127(10), 2478-2485 (2010-05-18)
Metastatic cancer is a major cause of morbidity and mortality. Current therapeutic options consist of chemotherapy, radiation or targeted therapies. However, these therapies are often toxic, effective over a small range of cancer types or result in drug resistance. Therefore
Sen-Ling Feng et al.
Journal of ginseng research, 44(2), 247-257 (2020-03-10)
Multidrug resistance (MDR) to chemotherapy drugs remains a major challenge in clinical cancer treatment. Here we investigated whether and how ginsenoside Rg5 overcomes the MDR mediated by ABCB1 transporter in vitro and in vivo. Cytotoxicity and colon formation as well as the
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| D2141-5MG | 04061833561706 |
| D2141-25MG | 04061833561690 |
